Acute Limb Ischemia Following a Mild Case of COVID-19

Coronavirus disease 2019 (COVID-19) was a novel virus that originated in China in November 2019 and is most known for its respiratory compromise; however, many patients have experienced vascular thrombosis as sequelae of COVID-19. It is thought that the virus causes endothelial cell damage and incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaisinskaya, Polina, VanHelmond, Taylor A, Reano, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217669/
https://www.ncbi.nlm.nih.gov/pubmed/35755547
http://dx.doi.org/10.7759/cureus.25234
_version_ 1784731701392441344
author Gaisinskaya, Polina
VanHelmond, Taylor A
Reano, Katherine
author_facet Gaisinskaya, Polina
VanHelmond, Taylor A
Reano, Katherine
author_sort Gaisinskaya, Polina
collection PubMed
description Coronavirus disease 2019 (COVID-19) was a novel virus that originated in China in November 2019 and is most known for its respiratory compromise; however, many patients have experienced vascular thrombosis as sequelae of COVID-19. It is thought that the virus causes endothelial cell damage and increased platelet and leukocyte adhesion, causing a hypercoagulable state. While the most common presentation of hypercoagulability associated with COVID-19 is venous thrombosis, there are reports of patients who present with acute limb ischemia. We present a case of acute leg ischemia in an otherwise asymptomatic patient with no atherosclerotic risk factors. 
format Online
Article
Text
id pubmed-9217669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92176692022-06-23 Acute Limb Ischemia Following a Mild Case of COVID-19 Gaisinskaya, Polina VanHelmond, Taylor A Reano, Katherine Cureus Cardiac/Thoracic/Vascular Surgery Coronavirus disease 2019 (COVID-19) was a novel virus that originated in China in November 2019 and is most known for its respiratory compromise; however, many patients have experienced vascular thrombosis as sequelae of COVID-19. It is thought that the virus causes endothelial cell damage and increased platelet and leukocyte adhesion, causing a hypercoagulable state. While the most common presentation of hypercoagulability associated with COVID-19 is venous thrombosis, there are reports of patients who present with acute limb ischemia. We present a case of acute leg ischemia in an otherwise asymptomatic patient with no atherosclerotic risk factors.  Cureus 2022-05-23 /pmc/articles/PMC9217669/ /pubmed/35755547 http://dx.doi.org/10.7759/cureus.25234 Text en Copyright © 2022, Gaisinskaya et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiac/Thoracic/Vascular Surgery
Gaisinskaya, Polina
VanHelmond, Taylor A
Reano, Katherine
Acute Limb Ischemia Following a Mild Case of COVID-19
title Acute Limb Ischemia Following a Mild Case of COVID-19
title_full Acute Limb Ischemia Following a Mild Case of COVID-19
title_fullStr Acute Limb Ischemia Following a Mild Case of COVID-19
title_full_unstemmed Acute Limb Ischemia Following a Mild Case of COVID-19
title_short Acute Limb Ischemia Following a Mild Case of COVID-19
title_sort acute limb ischemia following a mild case of covid-19
topic Cardiac/Thoracic/Vascular Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217669/
https://www.ncbi.nlm.nih.gov/pubmed/35755547
http://dx.doi.org/10.7759/cureus.25234
work_keys_str_mv AT gaisinskayapolina acutelimbischemiafollowingamildcaseofcovid19
AT vanhelmondtaylora acutelimbischemiafollowingamildcaseofcovid19
AT reanokatherine acutelimbischemiafollowingamildcaseofcovid19

Ejemplares similares